Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. scores highest on Earnings (90) and lowest on Nitro (37). Its PosiPenta is 56.54 out of 100, around the middle of similar companies.
On the Penta Grid this week, Collegium Pharmaceutical, Inc. is Grid #188 of 837 in the Healthcare sector in United States, and Grid #1,047 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. | 56.54 | 59 | 90 | 37 | 47 | 50 |
| Apnimed, Inc. | 43.15 | 44 | 49 | 42 | 14 | 66 |
| Varex Imaging Corporation | 65.62 | 50 | 80 | 99 | 51 | 48 |
| Phreesia, Inc. | 57.33 | 38 | 87 | 44 | 61 | 56 |
| Geron Corporation | 48.07 | 19 | 80 | 50 | 45 | 47 |
| Annexon, Inc. | 35.17 | 19 | 36 | 45 | 38 | 38 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 18.26 |
| P/B ratio | 2.42 |
EEarnings
| Trailing EPS | ₹120.29 |
| Forward EPS | ₹687.43 |
NNitro
| Price | 2196.44 |
| 52-week high | 4810.29 |
| 52-week low | 2029.74 |
| Fall from 52-week high | 54.3% |
TTorque
| Return on equity (ROE) | 17.61% |
| Debt-to-equity | 3.90 |
AAnchor
| Beta (price swings) | 0.73 |
| Market cap | ₹7,150 Cr |
| Insider holding | 1.15% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Collegium Pharmaceutical, Inc.'s PosiPenta score?
Collegium Pharmaceutical, Inc.'s PosiPenta is 56.54 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Collegium Pharmaceutical, Inc. stand on the Penta Grid?
On the Penta Grid this week, Collegium Pharmaceutical, Inc. is Grid #188 of 837 in the Healthcare sector in United States, and Grid #1,047 of 4,000 in United States.
Which PosiPenta pillar is strongest for Collegium Pharmaceutical, Inc.?
Earnings (growth), with a score of 90 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Collegium Pharmaceutical, Inc.?
Nitro (momentum), with a score of 37 out of 100: weaker than most similar companies.
Has Collegium Pharmaceutical, Inc.'s PosiPenta changed since last week?
Yes, it rose 13.04 points, from 43.50 to 56.54.
PositoAI is for research and education only and is not investment advice.